Changes in serum hepatic fibrosis markers in biochemical responders to interferon therapy for chronic hepatitis C.
Serum hepatic fibrosis markers (7s domain of type IV collagen, N-terminal peptide of type III procollagen, and hyaluronate) were determined during and after a 6-month interferon treatment of patients with chronic hepatitis C. Changes in these markers were compared among the patients who showed a sustained normalization of serum alanine transaminase (ALT) levels with and without eradication of serum hepatitis C virus RNA (complete responders and biochemical responders) and nonresponders. In the case of complete responders, the serum 7s domain of type IV collagen and the N-terminal peptide of type III procollagen levels decreased at the end and 24 weeks after the end of the treatment. Hyaluronate levels were significantly decreased 24 weeks after the end of the treatment, as compared with those prior to the treatment. During and after interferon treatment, changes in these markers in the case of biochemical responders were nearly the same as those in the complete responders. These results suggest that serum hepatic fibrosis markers decrease in patients with chronic hepatitis C who show a sustained normalization of ALT after interferon treatment, even if serum hepatitis C virus RNA fails to be eradicated.
Fukuzaki
T
Department of Internal Medicine and Molecular Science, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka, Japan
Kawata
S
Imai
Y
Tamura
S
Inada
M
Maeda
H
Shirai
Y
Maeda
Y
Yabuuchi
I
Kiriyama
K
Himeno
S
Toyoshima
H
Nishikawa
M
Kashihara
T
Minami
Y
Nishiuchi
M
Seki
K
Matsuzawa
Y